Bevacizumab and hereditary haemorrhagic telangiectasia

Ross P Cruikshank and Boris W Chern
Med J Aust 2011; 194 (6): . || doi: 10.5694/j.1326-5377.2011.tb02989.x
Published online: 21 March 2011

To the Editor: Hereditary haemorrhagic telangiectasia (HHT) or Osler–Weber–Rendu syndrome manifests as vascular dysplasia involving the nose, skin, lung, brain and gastrointestinal tract. It is an inherited disorder manifesting as unbalanced angiogenesis.1

  • Ross P Cruikshank
  • Boris W Chern

  • Redcliffe Hospital, Brisbane, QLD.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.